Government urged to delay new GMP system

The domestic pharmaceutical industry is calling for the Korea Food and Drug Administration to delay the implementation of a new global good manufacturing practice (GMP) system, while providing an allowance of at least five-year grace period and government support over facility investment, as a sizable investment is likely to be required for the innovation of current facilities and replacement o...